| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/06/2007 | CA2353847C Pulmonary drug delivery |
| 03/06/2007 | CA2320488C Strategically modified hepatitis b core proteins and their derivatives |
| 03/06/2007 | CA2141670C Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 03/06/2007 | CA2132833C Hepatitis vaccines containing 3-o-deacylated monophosphoryl lipid a |
| 03/01/2007 | WO2007025178A2 Rolyvalent multimeric compositions containing active polypeptides, pharmaceutical compositions and methods of using the same |
| 03/01/2007 | WO2007025166A2 Devices, compositions and methods for the protection and repair of cells and tissues |
| 03/01/2007 | WO2007024947A2 Canine influenza vaccines |
| 03/01/2007 | WO2007024921A2 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 03/01/2007 | WO2007024846A2 Anit-il-23 antibiodies |
| 03/01/2007 | WO2007024752A2 Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders |
| 03/01/2007 | WO2007024743A2 Proteolysis resistant antibody preparations |
| 03/01/2007 | WO2007024715A2 Dual variable domain immunoglobin and uses thereof |
| 03/01/2007 | WO2007024705A2 Method of treating depression using a tnf-alpha antibody |
| 03/01/2007 | WO2007024672A1 Use of a botulinum toxin to improve gastric emptying and/or to treat gerd |
| 03/01/2007 | WO2007024649A2 Methods of treating and preventing acute myocardial infarction |
| 03/01/2007 | WO2007024568A2 Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock |
| 03/01/2007 | WO2007024290A2 Nanoscale neuromodulating platform for retina neuron activation apparatus and method |
| 03/01/2007 | WO2007024222A1 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 03/01/2007 | WO2007024026A1 Biodegradable nanoparticle having t-cell recognizable epitope peptide immobilized thereon or encapsulated therein |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023815A1 Therapeutic drug for heart disease and virus disease |
| 03/01/2007 | WO2007023782A1 Neutralizing antibody directed against killer toxin-like protein, and use thereof |
| 03/01/2007 | WO2007023778A1 Novel anticancer concomitant drug |
| 03/01/2007 | WO2007023725A1 Gene vaccine |
| 03/01/2007 | WO2007023628A1 Secretory antigen 1 protein of babesia gibsoni, dna encoding the same and use thereof |
| 03/01/2007 | WO2007023307A1 Combinations comprising dmxaa for the treatment of cancer |
| 03/01/2007 | WO2007023302A1 Combinations comprising dmxaa for the treatment of cancer |
| 03/01/2007 | WO2007023287A1 Vectors and uses thereof |
| 03/01/2007 | WO2007022557A1 Mimotopes of epstein-barr virus (ebv) epitopes |
| 03/01/2007 | WO2007005389A9 F11 receptor (f11r) antagonists as therapeutic agents |
| 03/01/2007 | WO2006136392A3 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 03/01/2007 | WO2006133408A3 Breast cancer and prostate cancer assessment |
| 03/01/2007 | WO2006128082A3 Biomarkers for breast cancer |
| 03/01/2007 | WO2006119965A3 Growth factor mutants with altered biological attributes |
| 03/01/2007 | WO2006117241A3 Polypeptide, vaccine and use thereof |
| 03/01/2007 | WO2006114805A3 Use of hmgb2 and hmgb3 proteins for medical applications |
| 03/01/2007 | WO2006110589A8 Gammaretrovirus associated with cancer |
| 03/01/2007 | WO2006092795A3 Oligoribonucleotides and methods of use thereof for treatment of ocular scarring and other fibrotic conditions |
| 03/01/2007 | WO2006090291A3 Method for expanding cd4+ cd25+ t regulatory cells |
| 03/01/2007 | WO2006088481A3 Genetically engineered equine influenza virus and uses thereof |
| 03/01/2007 | WO2006086730A3 Inhibiting her2 shedding with matrix metalloprotease antagonists |
| 03/01/2007 | WO2006084466A3 Surface-located streptococcus pneumoniae polypeptides |
| 03/01/2007 | WO2006081259A3 Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 03/01/2007 | WO2006076032A3 Alphavirus replicon packaging constructs |
| 03/01/2007 | WO2006061723B1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 03/01/2007 | WO2006053110A3 Ovr110 antibody compositions and methods of use |
| 03/01/2007 | WO2006029220A3 Combination therapy with anti-ctla4 and anti-4-1bb antibodies |
| 03/01/2007 | WO2006021955A3 Use of bat monoclonal antibody for immunotherapy |
| 03/01/2007 | WO2006017857A3 Antibiotic resistance free dna vaccines |
| 03/01/2007 | WO2006002079A3 Hiv-1 neutralizing antibodies elicited by trimeric hiv-1 envelope glycoprotein complex |
| 03/01/2007 | WO2005017107A3 Specific binding agents to hepatocyte growth factor |
| 03/01/2007 | WO2003086277A3 Attenuated gram negative bacteria |
| 03/01/2007 | WO2003080675A3 MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-13 RECEPTOR ALPHA 1 (IL-13Rα1) |
| 03/01/2007 | US20070049737 Homogeneous preparations of il-28 and il-29 |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049550 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 03/01/2007 | US20070049546 Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals |
| 03/01/2007 | US20070049516 Use of Insulin for the Treatment of Cartilaginous Disorders |
| 03/01/2007 | US20070048862 Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines |
| 03/01/2007 | US20070048861 plasmid constructs useful for the delivery of DNA vaccines; having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses |
| 03/01/2007 | US20070048860 Carcinoembryonic antigen (CEA) peptides |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048844 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 03/01/2007 | US20070048843 Homogeneous preparations of IL-28 and IL-29 |
| 03/01/2007 | US20070048825 Compositions and methods for the diagnosis and treatment of tumor |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
| 03/01/2007 | US20070048809 Using monoclonal antibody NUH2 as diagnositic tool in identifying cell proliferative disorders of urogenital system in individual negative for prostate specific antigen |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048780 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors; kits for diagnosing infection and vaccines |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048336 Combination therapy of peptide vaccination and estramustine treatment |
| 03/01/2007 | US20070048335 Methods for treating pain and hyperhidrosis |
| 03/01/2007 | US20070048334 Use of a botulinum toxin to improve gastric emptying and/or to treat GERD |
| 03/01/2007 | US20070048333 CD4+ T-lymphocyte-specific Hepatitis C virus-epitopes |
| 03/01/2007 | US20070048332 Stabilized liquid anti-RSV antibody formulations |
| 03/01/2007 | US20070048331 Non-toxic mutants of pathogenic gram-negative bacteria |
| 03/01/2007 | US20070048330 Optimized multi-epitope constructs and uses thereof |
| 03/01/2007 | US20070048329 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
| 03/01/2007 | US20070048328 treating a food allergy; orally administer 100 mu g/kg or more of transforming growth factor-beta (TGF- beta ); no side effects |
| 03/01/2007 | US20070048327 Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy |
| 03/01/2007 | US20070048326 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | US20070048325 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 03/01/2007 | US20070048324 Antibody which binds fetal thymocytes, inhibitits cell proliferation and does not bind adult thymocytes; for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 03/01/2007 | US20070048323 Antibody treatment of lipomatous tumors |
| 03/01/2007 | US20070048322 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/01/2007 | US20070048321 Method for the treatment of fibrosis |
| 03/01/2007 | US20070048320 Method for indentifying modulators of PPIL2 useful for treating Alzheimer's disease |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048318 Method for treating psoriasis |
| 03/01/2007 | US20070048317 Method of treating fibroproliferative disorders |
| 03/01/2007 | US20070048316 Method of reducing proliferation of cells in a mammal |
| 03/01/2007 | US20070048315 monoclonal antibody, or antigen binding fragment thereof that binds to human IL-23p19 at an epitope comprising residues 133-140 of SEQ ID NO: 29; treatment of inflammatory, autoimmune, and proliferative disorders |
| 03/01/2007 | US20070048314 Process for preparing purified drug conjugates |
| 03/01/2007 | US20070048313 Hybridoma cell lines and monoclonal antibodies recognizing Prox1 |
| 03/01/2007 | US20070048312 Mixture comprising A beta -derived diffusible ligand (ADDL) specific immunoglobulin which binds soluble amyloid beta protein for use in diagnosis, prevention and treatment of nervous sytem disorders |
| 03/01/2007 | US20070048311 ANTI-INTERFERON-alpha ANTIBODIES |
| 03/01/2007 | US20070048310 Human ataxin-1-like polypeptide IMX97018 |
| 03/01/2007 | US20070048309 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048308 Nucleic acid encoding cytokine receptor zcytor17 |